SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Bertrand Hervé) "

Sökning: WFRF:(Bertrand Hervé)

  • Resultat 1-10 av 26
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Engert, Andreas, et al. (författare)
  • The European Hematology Association Roadmap for European Hematology Research : a consensus document
  • 2016
  • Ingår i: Haematologica. - Pavia, Italy : Ferrata Storti Foundation (Haematologica). - 0390-6078 .- 1592-8721. ; 101:2, s. 115-208
  • Tidskriftsartikel (refereegranskat)abstract
    • The European Hematology Association (EHA) Roadmap for European Hematology Research highlights major achievements in diagnosis and treatment of blood disorders and identifies the greatest unmet clinical and scientific needs in those areas to enable better funded, more focused European hematology research. Initiated by the EHA, around 300 experts contributed to the consensus document, which will help European policy makers, research funders, research organizations, researchers, and patient groups make better informed decisions on hematology research. It also aims to raise public awareness of the burden of blood disorders on European society, which purely in economic terms is estimated at (sic)23 billion per year, a level of cost that is not matched in current European hematology research funding. In recent decades, hematology research has improved our fundamental understanding of the biology of blood disorders, and has improved diagnostics and treatments, sometimes in revolutionary ways. This progress highlights the potential of focused basic research programs such as this EHA Roadmap. The EHA Roadmap identifies nine 'sections' in hematology: normal hematopoiesis, malignant lymphoid and myeloid diseases, anemias and related diseases, platelet disorders, blood coagulation and hemostatic disorders, transfusion medicine, infections in hematology, and hematopoietic stem cell transplantation. These sections span 60 smaller groups of diseases or disorders. The EHA Roadmap identifies priorities and needs across the field of hematology, including those to develop targeted therapies based on genomic profiling and chemical biology, to eradicate minimal residual malignant disease, and to develop cellular immunotherapies, combination treatments, gene therapies, hematopoietic stem cell treatments, and treatments that are better tolerated by elderly patients.
  •  
2.
  •  
3.
  • Bernatsky, Sasha, et al. (författare)
  • Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma
  • 2017
  • Ingår i: Lupus Science and Medicine. - : BMJ. - 2053-8790. ; 4:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: Determinants of the increased risk of diffuse large B-cell lymphoma (DLBCL) in SLE are unclear. Using data from a recent lymphoma genome-wide association study (GWAS), we assessed whether certain lupus-related single nucleotide polymorphisms (SNPs) were also associated with DLBCL. Methods: GWAS data on European Caucasians from the International Lymphoma Epidemiology Consortium (InterLymph) provided a total of 3857 DLBCL cases and 7666 general-population controls. Data were pooled in a random-effects meta-analysis. Results: Among the 28 SLE-related SNPs investigated, the two most convincingly associated with risk of DLBCL included the CD40 SLE risk allele rs4810485 on chromosome 20q13 (OR per risk allele=1.09, 95% CI 1.02 to 1.16, p=0.0134), and the HLA SLE risk allele rs1270942 on chromosome 6p21.33 (OR per risk allele=1.17, 95% CI 1.01 to 1.36, p=0.0362). Of additional possible interest were rs2205960 and rs12537284. The rs2205960 SNP, related to a cytokine of the tumour necrosis factor superfamily TNFSF4, was associated with an OR per risk allele of 1.07, 95% CI 1.00 to 1.16, p=0.0549. The OR for the rs12537284 (chromosome 7q32, IRF5 gene) risk allele was 1.08, 95% CI 0.99 to 1.18, p=0.0765. Conclusions: These data suggest several plausible genetic links between DLBCL and SLE.
  •  
4.
  • Cerhan, James R., et al. (författare)
  • Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma
  • 2014
  • Ingår i: Nature Genetics. - : Springer Science and Business Media LLC. - 1061-4036 .- 1546-1718. ; 46:11, s. 1233-1238
  • Tidskriftsartikel (refereegranskat)abstract
    • Diffuse large B cell lymphoma (DLBCL) is the most common lymphoma subtype and is clinically aggressive. To identify genetic susceptibility loci for DLBCL, we conducted a meta-analysis of 3 new genome-wide association studies (GWAS) and 1 previous scan, totaling 3,857 cases and 7,666 controls of European ancestry, with additional genotyping of 9 promising SNPs in 1,359 cases and 4,557 controls. In our multi-stage analysis, five independent SNPs in four loci achieved genome-wide significance marked by rs116446171 at 6p25.3 (EXOC2; P = 2.33 x 10(-21)), rs2523607 at 6p21.33 (HLA-B; P = 2.40 x 10(-10)), rs79480871 at 2p23.3 (NCOA1; P = 4.23 x 10(-8)) and two independent SNPs, rs13255292 and rs4733601, at 8q24.21 (PVT1; P = 9.98 x 10(-13) and 3.63 x 10(-11), respectively). These data provide substantial new evidence for genetic susceptibility to this B cell malignancy and point to pathways involved in immune recognition and immune function in the pathogenesis of DLBCL.
  •  
5.
  • Chernysheva, Ekaterina, et al. (författare)
  • Band alignment at Ag/ZnO(0001) interfaces : A combined soft and hard x-ray photoemission study
  • 2018
  • Ingår i: Physical Review B. - : AMER PHYSICAL SOC. - 2469-9950 .- 2469-9969. ; 97:23
  • Tidskriftsartikel (refereegranskat)abstract
    • Band alignment at the interface between evaporated silver films and Zn- or O-terminated polar orientations of ZnO is explored by combining soft and hard x-ray photoemissions on native and hydrogenated surfaces. Ultraviolet photoemission spectroscopy (UPS) is used to track variations of work function, band bending, ionization energy, and Schottky barrier during silver deposition. The absolute values of band bending and the bulk position of the Fermi level are determined on continuous silver films by hard x-ray photoemission spectroscopy (HAXPES) through a dedicated modeling of core levels. Hydrogenation leads to the formation of similar to 0.3 monolayer of donorlike hydroxyl groups on both ZnO-O and ZnO-Zn surfaces and to the release of metallic zinc on ZnO-Zn. However, no transition to an accumulation layer is observed. On bare surfaces, silver adsorption is cationic on ZnO(000 (1) over bar)-O [anionic on ZnO(0001)-Zn] at the earliest stages of growth as expected from polarity healing before adsorbing as a neutral species. UPS and HAXPES data appear quite consistent. The two surfaces undergo rather similar band bendings for all types of preparation. The downward band bending of V-bb,(ZnO-O) = -0.4 eV and V-bb,(ZnO-Zn) = -0.6 eV found for the bare surfaces is reinforced upon hydrogenation (V-bb,(ZnO-O+H) = -1.1 eV, V-bb,(ZnO-Zn+H) = -1.2 eV). At the interface with Ag, a unique value of band bending of -0.75 eV is observed. While exposure to atomic hydrogen modulates strongly the energetic positions of the surface levels, a similar Schottky barrier of 0.5-0.7 eV is found for thick silver films on the two surfaces.
  •  
6.
  • Machiela, Mitchell J., et al. (författare)
  • Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes
  • 2016
  • Ingår i: Human Molecular Genetics. - : Oxford University Press (OUP). - 0964-6906 .- 1460-2083. ; 25:8, s. 1663-1676
  • Tidskriftsartikel (refereegranskat)abstract
    • Evidence from a small number of studies suggests that longer telomere length measured in peripheral leukocytes is associated with an increased risk of non-Hodgkin lymphoma (NHL). However, these studies may be biased by reverse causation, confounded by unmeasured environmental exposures and might miss time points for which prospective telomere measurement would best reveal a relationship between telomere length and NHL risk. We performed an analysis of genetically inferred telomere length and NHL risk in a study of 10 102 NHL cases of the four most common B-cell histologic types and 9562 controls using a genetic risk score (GRS) comprising nine telomere length-associated single-nucleotide polymorphisms. This approach uses existing genotype data and estimates telomere length by weighing the number of telomere length-associated variant alleles an individual carries with the published change in kb of telomere length. The analysis of the telomere length GRS resulted in an association between longer telomere length and increased NHL risk [four B-cell histologic types combined; odds ratio (OR) = 1.49, 95% CI 1.22-1.82, P-value = 8.5 x 10(-5)]. Subtype-specific analyses indicated that chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) was the principal NHL subtype contributing to this association (OR = 2.60, 95% CI 1.93-3.51, P-value = 4.0 x 10(-10)). Significant interactions were observed across strata of sex for CLL/SLL and marginal zone lymphoma subtypes as well as age for the follicular lymphoma subtype. Our results indicate that a genetic background that favors longer telomere length may increase NHL risk, particularly risk of CLL/SLL, and are consistent with earlier studies relating longer telomere length with increased NHL risk.
  •  
7.
  • Adjuik, Martin A., et al. (författare)
  • The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria : a meta-analysis of individual patient data
  • 2015
  • Ingår i: BMC Medicine. - : Springer Science and Business Media LLC. - 1741-7015. ; 13
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Artesunate-amodiaquine (AS-AQ) is one of the most widely used artemisinin-based combination therapies (ACTs) to treat uncomplicated Plasmodium falciparum malaria in Africa. We investigated the impact of different dosing strategies on the efficacy of this combination for the treatment of falciparum malaria. Methods: Individual patient data from AS-AQ clinical trials were pooled using the WorldWide Antimalarial Resistance Network (WWARN) standardised methodology. Risk factors for treatment failure were identified using a Cox regression model with shared frailty across study sites. Results: Forty-three studies representing 9,106 treatments from 1999-2012 were included in the analysis; 4,138 (45.4%) treatments were with a fixed dose combination with an AQ target dose of 30 mg/kg (FDC), 1,293 (14.2%) with a non-fixed dose combination with an AQ target dose of 25 mg/kg (loose NFDC-25), 2,418 (26.6%) with a non-fixed dose combination with an AQ target dose of 30 mg/kg (loose NFDC-30), and the remaining 1,257 (13.8%) with a co-blistered non-fixed dose combination with an AQ target dose of 30 mg/kg (co-blistered NFDC). The median dose of AQ administered was 32.1 mg/kg [IQR: 25.9-38.2], the highest dose being administered to patients treated with co-blistered NFDC (median = 35.3 mg/kg [IQR: 30.6-43.7]) and the lowest to those treated with loose NFDC-25 (median = 25.0 mg/kg [IQR: 22.7-25.0]). Patients treated with FDC received a median dose of 32.4 mg/kg [IQR: 27-39.0]. After adjusting for reinfections, the corrected antimalarial efficacy on day 28 after treatment was similar for co-blistered NFDC (97.9% [95% confidence interval (CI): 97.0-98.8%]) and FDC (98.1% [95% CI: 97.6%-98.5%]; P = 0.799), but significantly lower for the loose NFDC-25 (93.4% [95% CI: 91.9%-94.9%]), and loose NFDC-30 (95.0% [95% CI: 94.1%-95.9%]) (P < 0.001 for all comparisons). After controlling for age, AQ dose, baseline parasitemia and region; treatment with loose NFDC-25 was associated with a 3.5-fold greater risk of recrudescence by day 28 (adjusted hazard ratio, AHR = 3.51 [95% CI: 2.02-6.12], P < 0.001) compared to FDC, and treatment with loose NFDC-30 was associated with a higher risk of recrudescence at only three sites. Conclusions: There was substantial variation in the total dose of amodiaquine administered in different AS-AQ combination regimens. Fixed dose AS-AQ combinations ensure optimal dosing and provide higher antimalarial treatment efficacy than the loose individual tablets in all age categories.
  •  
8.
  • Amaral, Andre F. S., et al. (författare)
  • Chronic airflow obstruction and ambient particulate air pollution
  • 2021
  • Ingår i: Thorax. - : BMJ Publishing Group Ltd. - 0040-6376 .- 1468-3296. ; 76:12, s. 1236-1241
  • Tidskriftsartikel (refereegranskat)abstract
    • Smoking is the most well-established cause of chronic airflow obstruction (CAO) but particulate air pollution and poverty have also been implicated. We regressed sex-specific prevalence of CAO from 41 Burden of Obstructive Lung Disease study sites against smoking prevalence from the same study, the gross national income per capita and the local annual mean level of ambient particulate matter (PM2.5) using negative binomial regression. The prevalence of CAO was not independently associated with PM2.5 but was strongly associated with smoking and was also associated with poverty. Strengthening tobacco control and improved understanding of the link between CAO and poverty should be prioritised.
  •  
9.
  • Burney, Peter, et al. (författare)
  • Prevalence and Population-Attributable Risk for Chronic Airflow Obstruction in a Large Multinational Study
  • 2021
  • Ingår i: American Journal of Respiratory and Critical Care Medicine. - 1073-449X .- 1535-4970. ; 203:11, s. 1353-1365
  • Tidskriftsartikel (refereegranskat)abstract
    • Rationale: The Global Burden of Disease program identified smoking and ambient and household air pollution as the main drivers of death and disability from chronic obstructive pulmonary disease (COPD).Objectives: To estimate the attributable risk of chronic airflow obstruction (CAO), a quantifiable characteristic of COPD, due to several risk factors.Methods: The Burden of Obstructive Lung Disease study is a cross-sectional study of adults, aged ≥40, in a globally distributed sample of 41 urban and rural sites. Based on data from 28,459 participants, we estimated the prevalence of CAO, defined as a postbronchodilator FEV1-to-FVC ratio less than the lower limit of normal, and the relative risks associated with different risk factors. Local relative risks were estimated using a Bayesian hierarchical model borrowing information from across sites. From these relative risks and the prevalence of risk factors, we estimated local population attributable risks.Measurements and Main Results: The mean prevalence of CAO was 11.2% in men and 8.6% in women. The mean population attributable risk for smoking was 5.1% in men and 2.2% in women. The next most influential risk factors were poor education levels, working in a dusty job for ≥10 years, low body mass index, and a history of tuberculosis. The risk of CAO attributable to the different risk factors varied across sites.Conclusions: Although smoking remains the most important risk factor for CAO, in some areas, poor education, low body mass index, and passive smoking are of greater importance. Dusty occupations and tuberculosis are important risk factors at some sites.
  •  
10.
  • Callegaro, Sara, et al. (författare)
  • Upper and lower crust recycling in the source of CAMP basaltic dykes from southeastern North America
  • 2013
  • Ingår i: Earth and Planetary Science Letters. - 0012-821X .- 1385-013X. ; 376, s. 186-199
  • Tidskriftsartikel (refereegranskat)abstract
    • The densest dykes swarm of the Central Atlantic magmatic province (CAMP) occur in southeastern North America (SENA) and were intruded between 202 and 195 Ma during Pangea break-up. New combined geochemical data (major and trace elements, Sr–Nd–Pb–Os isotopes) constrain the mantle source of these magmatic bodies and their evolution path. While Sr–Nd isotopic compositions for SENA rocks (87Sr/86Sr200Ma 0.70438–0.70880 and 143Nd/144Nd200Ma 0.51251–0.51204) fall within the low-Ti CAMP field, Pb–Pb isotopes (206Pb/204Pb200Ma 17.46–18.85, 207Pb/204Pb200Ma 15.54–15.65, 208Pb/204Pb200Ma 37.47–38.76) are peculiar to this area of the CAMP and cover a considerable span of compositions, especially in 206Pb/204Pb200Ma. Given the generally unradiogenic Os isotopic compositions (187Os/188Os200Ma 0.127–0.144) observed and the lack of correlation between these and other geochemical markers, crustal contamination during the evolution of SENA dykes must have been limited (less than 10%). Thus the isotopic variation is interpreted to reside primarily within the mantle source. These observations, coupled with typical continental signatures in trace elements (positive anomaly in Pb and negative anomalies in Ti and Nb), require another means of conveying a continental flavor to these magmas, which is here hypothesized to be the shallow recycling within the upper mantle of subducted lower and upper crustal materials. Pseudo-ternary mixing models show that a maximum of 10% recycled crust is enough to explain their trace element patterns as well as their isotopic heterogeneity. Looking at the larger picture of the origin of the CAMP, the thermal contribution of a mantle plume cannot be ruled out due to the relatively high mantle potential temperatures (1430–1480 °C) calculated for high-Fo SENA olivines. Nevertheless, our results suggest that the chemical involvement of a mantle plume is negligible (less than 5%) if either a C- or an EM-flavored plume is considered. Rather, the possibility of a PREMA-flavored mantle plume, enriched by 5–20% recycled crustal material, remains a possible, though less plausible, source for these tholeiites.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 26
Typ av publikation
tidskriftsartikel (24)
forskningsöversikt (2)
Typ av innehåll
refereegranskat (26)
Författare/redaktör
Glimelius, Bengt (4)
Smedby, Karin E. (4)
Adami, Hans Olov (4)
Melbye, Mads (4)
Berndt, Sonja I (4)
Chanock, Stephen J (4)
visa fler...
Albanes, Demetrius (4)
Giles, Graham G (4)
Vineis, Paolo (4)
North, Kari E. (4)
Boffetta, Paolo (4)
Offit, Kenneth (4)
Spinelli, John J. (4)
Teras, Lauren R. (4)
Kraft, Peter (4)
Diver, W Ryan (4)
Virtamo, Jarmo (4)
Hjalgrim, Henrik (4)
Brennan, Paul (4)
Vermeulen, Roel C. H ... (4)
Bracci, Paige M (4)
Holly, Elizabeth A (4)
Zeleniuch-Jacquotte, ... (4)
Hartge, Patricia (4)
Foretova, Lenka (4)
Vijai, Joseph (4)
Becker, Nikolaus (4)
Rothman, Nathaniel (4)
Lan, Qing (4)
McKay, James (4)
Conde, Lucia (4)
Skibola, Christine F ... (4)
Marzoli, Andrea (4)
Cerhan, James R. (4)
Wang, Sophia S. (4)
Angelucci, Emanuele (4)
Benavente, Yolanda (4)
Bertrand, Kimberly A ... (4)
Birmann, Brenda M. (4)
Brooks-Wilson, Angel ... (4)
Clavel, Jacqueline (4)
Cozen, Wendy (4)
De Roos, Anneclaire ... (4)
de Sanjose, Silvia (4)
Dogan, Ahmet (4)
Ghesquieres, Herve (4)
Habermann, Thomas M. (4)
Haioun, Corinne (4)
Holford, Theodore R. (4)
Jackson, Rebecca D. (4)
visa färre...
Lärosäte
Uppsala universitet (12)
Karolinska Institutet (10)
Lunds universitet (9)
Umeå universitet (4)
Naturhistoriska riksmuseet (4)
Stockholms universitet (3)
visa fler...
Linköpings universitet (2)
Göteborgs universitet (1)
Kungliga Tekniska Högskolan (1)
Chalmers tekniska högskola (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (26)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (14)
Naturvetenskap (12)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy